Pipeline coverage Archives | DelveInsight Business Research

Business Cocktail

Nov 10, 2017• Business Consultant

Notizia

Feb 28, 2017• Notizia

Prosecutors rope Pfizer into fast-growing copay assistance probe After first focusing on biotech and speciality pharma, the feds have made...

The Business Cocktail

Feb 16, 2017• The Business Cocktail

Mead Johnson Acquired By Reckitt Benckiser for $16.6 Billion Mead Johnson Nutrition Company (MJN), the manufacturer of infant formula and...

Notizia

Feb 7, 2017• Notizia

Nav1.7 Blockers- New Genre of Pain Relief Therapy

Aug 22, 2016• Articles

Voltage-gated sodium channels are membrane proteins, a polypeptide chain of more than 1800 amino acids that conduct sodium ions at high...

Global atrial fibrillation market is expected to grow to $12.5 billion by 2020

May 12, 2016• Anti-coagulants, Atrial Fibrillation, Business Consultant, CVS Indications, DelveInsight's Drug Report, Pharma Consultant, Specialized Reports

Global AF market was $7.2 billion in 2015 and expected to grow to $12.5 billion by 2020 with and compound annual growth rate (CAGR) of...

PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016

Feb 8, 2016• DelveInsight's Oncology based Reports, PD-1 and PD-L1 inhibitors, Pharma Consultant, Specialized Reports

LAG-3 Antagonists, TIM-3 Antagonists; OX40 Agonists- Pipeline Insights, 2016 – A DelveInsight Report

Jan 21, 2016• Specialized Reports

DelveInsight, the leading market research and consulting company has added new report “LAG-3 Antagonists, TIM-3 Antagonists & OX40...

Chimeric Antigen Receptor T cell Immunotherapy Market

Jan 21, 2016• Specialized Reports

DelveInsight, the leading market research and consulting company has added new report “Chimeric Antigen Receptor (CAR) T cell...

Head and Neck Squamous Cell Carcinoma -Pipeline Insights, 2016

Jan 12, 2016• DelveInsight's Indication Pipeline Reports, Uncategorized

Tag: Pipeline coverage

Business Cocktail

Notizia

The Business Cocktail

Notizia

Nav1.7 Blockers- New Genre of Pain Relief Therapy

Global atrial fibrillation market is expected to grow to $12.5 billion by 2020

PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016

LAG-3 Antagonists, TIM-3 Antagonists; OX40 Agonists- Pipeline Insights, 2016 – A DelveInsight Report

Chimeric Antigen Receptor T cell Immunotherapy Market

Head and Neck Squamous Cell Carcinoma -Pipeline Insights, 2016

Popular Posts

Recent Posts

Whitepaper/Newsletter

Categories

Trending Posts

Eli Lilly’s COVID-19 Antibody trial; Approval for Oriahnn; Gilead’s Remdesivir Clinical Trials result; Russia approves Avifavir to treat Covid-19

An Ageing Population and Upcoming Therapies: What is shaping the Alzheimer’s Disease Market Scenario?

One of the leading causes of blindness, and a sight-threatening disease, Uveitis, now has novel treatment approaches in its pipeline

Startup focuses tumors with CAR-T; AbCellera grabs USD 105M; Gilead inks USD 2B deal; GSK’s anti-BCMA antibody receives a boost

Precision Medicine: An emerging approach to conventional treatment

Algernon’s NP-120; FDA nod to 4DMedical tool; SaNOtize’s NORSTM trial; Pole’s capital increase

R&D and Upcoming therapies Paving the Way for a Potential and Better Cure for Immune Thrombocytopenia

Hunter Syndrome Market experiences a positive push as the pharma companies spot the untapped opportunities

CanSino deals with Precision; Atea raises USD 215 M; Applied Molecular Transport targets for USD 100 M IPO; Cell therapy repairs multiple sclerosis in mice

Keeping a track on COVID-19 through Wearable Technology

Sections